The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects

Detalles Bibliográficos
Autores principales: Vicenti, Ilaria, Gatti, Francesca, Scaggiante, Renzo, Boccuto, Adele, Zago, Daniela, Basso, Monica, Dragoni, Filippo, Parisi, Saverio Giuseppe, Zazzi, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329626/
https://www.ncbi.nlm.nih.gov/pubmed/34342854
http://dx.doi.org/10.1007/s15010-021-01680-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329626/
https://www.ncbi.nlm.nih.gov/pubmed/34342854
http://dx.doi.org/10.1007/s15010-021-01680-z

Ejemplares similares